8:00 – 8:15 am

ACADEMIA/INDUSTRY/FDA/NIH ROUNDTABLE ON MIDDLE MENINGEAL ARTERY(MMA): A PATHWAY TO INNOVATIVE TREATMENTS, NEURO-AI/ROBOTICS/AUTOMATION AND NON-CLINICAL REQUIREMENTS IN NEURO-IR                       

Location: Metropolitan Galleries 1-3

Chairs: Ajay Wakhloo, TUFTS University School of Medicine, USA
Adam Arthur, University of Tennessee, USA

Introduction: Marc Fisher, Beth Israel Diaconess, Harvard Medical School, Boston, MA

  8:15 – 11:00 am

SESSION 1: MIDDLE MENINGEAL ARTERY (MMA): A PATHWAY TO INNOVATIVE TREATMENTS

Location: Metropolitan Galleries 1-3

8:15 – 8:35
REFRACTORY MIGRAINE
08:15 – 08:25 Presentation by Adnan Qureshi, University of Missouri, School of Medicine, Columbia, MO
08:25 – 08:35 Comments by Italo Linfante, Miami Cardiac and Vascular Institute and Baptist Neuroscience Institute, Miami, FL

8:35 – 9:00
ENDOVASCULAR ACCESS TO SUDURAL SPACE AND BRAIN SURFACE
08:35 – 08:45 Presentation by Luis Savastano, University of California, San Francisco, CA
08:45 – 08:55 Presentation by Jose Morales, Pacific Neuroscience Institute, CA
08:55 – 09:00 Comments by Pedro Lylyk, University of Buenos Aires, Argentina

9:00 – 9:30
MMA INFUSIONS/EMBOLIZATION FOR HA
09:00 – 09:20 Presentation by Peter Kan, UTMB, Galveston, TX
09:20 – 09:30 Comments by Akash Patel, Baylor University, Houston, TX

9:30 – 9:50
REQUIREMENTS FOR A NOVEL LIQUID EMBOLIC AGENT
09:30 – 09:40 Presentation by Upma Sharma, Arsenal, Boston, MA
09:40 – 09:50 Comments by Guilherme Dabus, Miami Cardiac and Vascular Institute and Baptist Neuroscience Institute, Miami, FL

09:50 – 11:00 ROUNDTABLE PANEL DISCUSSION
Chris Kellner, Mt Sinai, NYC, NY;
David Fiorella, Stonybrook University School of Medicine, Stonybrook, NY
Violiza Inoa,Semmes Murphey Clinic, TN
David Altschul,Montefiore Medical Center, NY;
Christopher Loftus, FDA
William Ashley, FDA

  11:15 am– 1:30 pm

SESSION 2: NON-CLINICAL REQUIREMENTS IN NEURO-IR

Location: Metropolitan Galleries 1-3

Chairs: Matthew Gounis, University of Massachusetts Chan School of Medicine, USA
Ajay Wakhloo, TUFTS University School of Medicine, Worcester, MA

11:15 – 11:45
VALUE OF BIOLOGICAL SYSTEMS
11:15 – 11:30  Presentation by Gabriela Suarez-Mier, FDA
11:30 – 11:45 Comments by TBA

11:45 – 12:30
VALUE OF SIMULATED USE EXPERIMENTATION
11:45 – 12:00 Presentation by Steven Kreuzer, University of Texas at Austin
12:00 – 12:15 Comments by Demetrius Lopes, Advocate Health,Chicago,IL
12:15 – 12:30 Comments by Ramesh Grandhi, University of Utah, Salt Lake City, UT

12:30 – 1:30
ROUNDTABLE PANEL DISCUSSION

Vania Anagnostakou, UMASS Chan School of Medicine, Worcester, MA;
Carlos Pena, University of Buffalo, NY;
Gabriela Suarez-Mier, FDA
Naira Muradyan, FDA

  2:30 – 5:00 pm

SESSION 3: AI & ROBOTICS

Location: Metropolitan Galleries 1-3

Chairs: Vitor Pereira, University of Toronto and St. Michael’s Hospital, Canada
Ferdinand Hui, Queen’s University Medical Group, Honolulu, HI
David Liebeskind, University of California, Los Angelis, CA

2:30 – 3:30 THE EU AI ACT 2024: IMPLICATIONS FOR U.S. HEALTH CARE

2:30 – 2:45 Introduction to AI by Andrew Menard, Johns Hopkins, MA
2:45 – 3:00 Presentation by Mathias Unberath, Johns Hopkins, MA
3:00 – 3:15 Presentation by Tina M. Morrison, Senior Executive, Science Advisor to FDA, Stanford, CA
3:15 – 3:30 Comments by Joshua Hirsch, MGB, Harvard Medical School, Boston, MA

3:30 – 4:00 ROBOTICS
3:30 – 3:45 Presentation by Omar Choudhri, Mercy Health St Vincent, USA
3:45 – 4:00 Comments by Adnan Siddiqui, SUNY Buffalo, Buffalo, NY

4:00 – 5:00
ROUNDTABLE PANEL DISCUSSION

Tina M. Morrison, Senior Executive, Science Advisor to FDA, Stanford, CA;
Yasmin N Aziz, University of Cincinnati College of Medicine, OH;
Ameer Hassan, University of Texas, Austin, TX;
Quill Turk, University of South Carolina-Greenville, SC;
Michael Floehler, Vanderbilt University Medical Center
Sara Thompson, FDA
Patrick Antkowiak, FDA